🚀 Join Us as a Regulatory Affairs Associate – Chippenham (Hybrid)
Location: Chippenham, 2 days a week onsite (Hybrid)
Contract: Permanent
Are you passionate about healthcare innovation and regulatory excellence? Alliance is looking for a Regulatory Affairs Associate (known internally as a Regulatory Scientist) to join our Global Innovation and Scientific Affairs team and drive regulatory strategy across medical devices, cosmetics, and food supplements.
At Alliance, we specialise in advanced skincare solutions (KeloCote, Hydomol, and more) and vitamins, minerals & supplements (MacuShield, Forceval & Amberen….) Backed by innovation and driven by purpose, we're on an exciting journey of transformation and commercial acceleration
Why this role matters:
You’ll be the go-to expert ensuring our products meet global regulatory standards, supporting innovation, and helping our business thrive in compliance with regulations. From maintaining medical device records in EUDAMED to advising cross-functional teams on regulatory strategy, your expertise will make an impact.
What you’ll do:
- Implement regulatory strategies to support product compliance and commercial success.
- Support launches of innovative new products.
- Maintain and submit regulatory documentation and ensure EMEA portfolio compliance.
- Keep internal records aligned with REACH and UK REACH requirements.
- Lead QMS activities and provide regulatory guidance across teams.
- Represent Alliance in regulatory forums and industry discussions.
Who we’re looking for:
- BSc/MSc in Life Sciences, Nutrition, Food Science, Pharmacy, Chemistry, or related field.
- Strong understanding of UK/EU medical devices, cosmetics, and food supplement regulations; global exposure a plus.
- Experience with regulatory dossiers, notifications, and documentation submissions.
- Working knowledge of QMS processes and compliance activities.
- Excellent regulatory writing and documentation management skills.
- Proven ability to guide teams through regulatory challenges and support new product launches.